Kamada ^{Priced, Nasdaq: KMDA}

Provides plasma-derived protein therapeutics mostly in Israel and the US.

Industry: Health Care

First Day Return: +9.2%

KMDA

Provides plasma-derived protein therapeutics mostly in Israel and the US.

IPO News for Kamada

US IPO Recap: May ends with 30 pricings, two billion-dollar deals set for June 06/02/13
Kamada prices IPO at $9.25, raising $52 million 05/31/13
2 US IPOs planned for the week of May 27 05/27/13

IPO Data
IPO Date	05/30/2013
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$52
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Headquarters	Ness Ziona, Israel
Founded	1990
Employees at IPO	292
Website www.kamada.com

IPO News for Kamada

US IPO Recap: May ends with 30 pricings, two billion-dollar deals set for June 06/02/13
Kamada prices IPO at $9.25, raising $52 million 05/31/13
2 US IPOs planned for the week of May 27 05/27/13

Kamada (KMDA) Performance